These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17384012)

  • 41. Human pro-B-type natriuretic peptide is processed in the circulation in a rat model.
    Semenov AG; Seferian KR; Tamm NN; Artem'eva MM; Postnikov AB; Bereznikova AV; Kara AN; Medvedeva NA; Katrukha AG
    Clin Chem; 2011 Jun; 57(6):883-90. PubMed ID: 21474642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure--different proBNP-108 to BNP-32 ratios in atrial and ventricular overload.
    Nishikimi T; Minamino N; Ikeda M; Takeda Y; Tadokoro K; Shibasaki I; Fukuda H; Horiuchi Y; Oikawa S; Ieiri T; Matsubara M; Ishimitsu T
    Heart; 2010 Mar; 96(6):432-9. PubMed ID: 19966110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
    Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.
    Hammerer-Lercher A; Ludwig W; Falkensammer G; Müller S; Neubauer E; Puschendorf B; Pachinger O; Mair J
    Clin Chem; 2004 Jul; 50(7):1174-83. PubMed ID: 15142976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
    Rutten JH; Boomsma F; Van den Meiracker AH
    Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2553-7. PubMed ID: 18074722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure.
    Masson S; Vago T; Baldi G; Salio M; De Angelis N; Nicolis E; Maggioni AP; Latini R; Norbiato G; Bevilacqua M
    Clin Chem Lab Med; 2002 Aug; 40(8):761-3. PubMed ID: 12392300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
    Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
    Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.
    O'Hanlon R; O'Shea P; Ledwidge M; O'Loughlin C; Lange S; Conlon C; Phelan D; Cunningham S; McDonald K
    J Card Fail; 2007 Feb; 13(1):50-5. PubMed ID: 17339003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
    Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
    Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [BNP or NT-proBNP: "that is the question"].
    Lebrun C; Neuder Y; Pison C; Chouri N; Barnoud D; Belle L; Beaune G
    Ann Biol Clin (Paris); 2007; 65(5):533-8. PubMed ID: 17913672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
    Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.